0001225208-22-010120.txt : 20220907 0001225208-22-010120.hdr.sgml : 20220907 20220907163225 ACCESSION NUMBER: 0001225208-22-010120 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220906 FILED AS OF DATE: 20220907 DATE AS OF CHANGE: 20220907 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahoney Michael F CENTRAL INDEX KEY: 0001533022 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 221231524 MAIL ADDRESS: STREET 1: BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2022-09-06 0000885725 BOSTON SCIENTIFIC CORP BSX 0001533022 Mahoney Michael F 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 1 Chairman, President & CEO Common Stock 2022-08-30 5 G 0 365457.0000 0.0000 D 1767665.0000 D Common Stock 2022-09-06 4 M 0 82567.0000 7.3900 A 1850232.0000 D Common Stock 2022-09-06 4 M 0 43261.0000 13.0800 A 1893493.0000 D Common Stock 2022-09-06 4 S 0 125828.0000 40.4863 D 1767665.0000 D Stock Option (Right to Buy) 13.0800 2022-09-06 4 M 0 43261.0000 0.0000 D 2024-02-24 Common Stock 43261.0000 259561.0000 D Stock Option (Right to Buy) 7.3900 2022-09-06 4 M 0 82567.0000 0.0000 D 2023-02-28 Common Stock 82567.0000 165134.0000 D This transaction involved a gift of securities by the reporting person to the Michael F. Mahoney 2 Year Qualified Annuity Trust - 2022, which is administered by an independent trustee. The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan. Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $40.23 to $40.69, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 24, 2015, the first anniversary of the date of grant. Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. /s/ Susan Thompson, Attorney-in-Fact 2022-09-07